FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2957677739> ?p ?o ?g. }

• W2957677739 endingPage "485" @default.
• W2957677739 startingPage "485" @default.
• W2957677739 abstract "485 Objectives: Three Fluorine 18-labelled tracers are currently commercially available to measure cerebral amyloid pathology to assist in the diagnosis of possible Alzheimer’s Disease (AD); Amyvid, Vizamyl and Neuraceq. Although scanning protocols are relatively similar across the tracers, FDA-/EMA approved visual rating guidelines to render a scan as positive or negative considerably differ. These differences include color scale used, intensity-scaling, definitions of a region as well as spatial and signal thresholds to determine positivity. Standardization of visual reading would however be highly desirable in order to ensure that diagnostic classification, patient selection and therapeutic decisions are taken on a comparable basis, independently of the tracer used. To this end, we examined the comparability of different FDA-/EMA visual interpretation protocols on the three different commercially available amyloid tracers. Methods: In a multicentric approach, a total of 18 PET-Scans were compiled for this study (6 scans for each of the three tracers, matched for diagnostic categories). Each scan was pre-categorized with tracer-specific thresholds into amyloid positive or negative and submitted to an in-house-created online rating tool. On this platform, every single scan was presented for reading according to each of the three visual ratings schemes to a multi-center team of certified expert readers from Australia, Europe and the US. The certified raters were blind to clinical category and type of tracer used and were instructed to give a binary classification if a scan was positive or not. We analyzed intra- and interrater reliability and further assessed which visual rating schemes produces the highest reliability across tracers. Finally, we compared the correspondence of each response with the binary pre-classification based on a quantitative threshold. Results: Intrarater-reliability showed good to very good agreement (kapparange= .74-.80; kappaSE = .05-.05) across all reads. Irrespective of the tracer all three visual rating approaches also reached good interrater-reliability, with Vizamyl and Neuraceq criteria leading to the highest values (kapparange=.70-.80; kappaSE = .08-.07). When comparing the agreement of each expert rater’s response with the quantitatively pre-determined category of amyloid-positive or -negative, agreement rates although very high, varied among expert readers (Neuraceq approach: 80-95 %; Vizamyl approach: 90-93 %; Amyvid approach: 85-90 %). Conclusion: Our preliminary data of this ongoing study suggests that for visual assessment with regard to non-quantitative evaluation, established FDA-/EMA-approved interpretation guidelines may be sufficient to ensure relatively good levels of standardization with regard to classification into amyloid-positive and -negative subjects. However, a certain degree of variance remained. To potentially further improve standardization of visual rating, we are currently developing and evaluating a unified visual rating scheme that may enhance interrater-reliability and simplify interpretation of amyloid-scans also for the less-experienced user. We further investigate how interrater-reliability may vary as a function of diagnostic group. Together, the CAPATINs Study aims to further improve standardization of visual rating of amyloid-PET studies." @default.
• W2957677739 created "2019-07-23" @default.
• W2957677739 creator A5000636220 @default.
• W2957677739 creator A5003042664 @default.
• W2957677739 creator A5008894116 @default.
• W2957677739 creator A5019373426 @default.
• W2957677739 creator A5022818431 @default.
• W2957677739 creator A5025142464 @default.
• W2957677739 creator A5034480643 @default.
• W2957677739 creator A5037230816 @default.
• W2957677739 creator A5037412930 @default.
• W2957677739 creator A5055885632 @default.
• W2957677739 creator A5058052951 @default.
• W2957677739 creator A5065258380 @default.
• W2957677739 creator A5071341444 @default.
• W2957677739 creator A5072366997 @default.
• W2957677739 creator A5073895168 @default.
• W2957677739 creator A5075747770 @default.
• W2957677739 creator A5079134234 @default.
• W2957677739 creator A5081304921 @default.
• W2957677739 date "2018-05-01" @default.
• W2957677739 modified "2023-10-08" @default.
• W2957677739 title "Comparing Amyloid PET Tracers and Interpretation Strategies: First Results from the CAPTAINs Study" @default.
• W2957677739 hasPublicationYear "2018" @default.
• W2957677739 type Work @default.
• W2957677739 sameAs 2957677739 @default.
• W2957677739 citedByCount "0" @default.
• W2957677739 crossrefType "journal-article" @default.
• W2957677739 hasAuthorship W2957677739A5000636220 @default.
• W2957677739 hasAuthorship W2957677739A5003042664 @default.
• W2957677739 hasAuthorship W2957677739A5008894116 @default.
• W2957677739 hasAuthorship W2957677739A5019373426 @default.
• W2957677739 hasAuthorship W2957677739A5022818431 @default.
• W2957677739 hasAuthorship W2957677739A5025142464 @default.
• W2957677739 hasAuthorship W2957677739A5034480643 @default.
• W2957677739 hasAuthorship W2957677739A5037230816 @default.
• W2957677739 hasAuthorship W2957677739A5037412930 @default.
• W2957677739 hasAuthorship W2957677739A5055885632 @default.
• W2957677739 hasAuthorship W2957677739A5058052951 @default.
• W2957677739 hasAuthorship W2957677739A5065258380 @default.
• W2957677739 hasAuthorship W2957677739A5071341444 @default.
• W2957677739 hasAuthorship W2957677739A5072366997 @default.
• W2957677739 hasAuthorship W2957677739A5073895168 @default.
• W2957677739 hasAuthorship W2957677739A5075747770 @default.
• W2957677739 hasAuthorship W2957677739A5079134234 @default.
• W2957677739 hasAuthorship W2957677739A5081304921 @default.
• W2957677739 hasConcept C114614502 @default.
• W2957677739 hasConcept C121332964 @default.
• W2957677739 hasConcept C138496976 @default.
• W2957677739 hasConcept C154945302 @default.
• W2957677739 hasConcept C15744967 @default.
• W2957677739 hasConcept C163258240 @default.
• W2957677739 hasConcept C169760540 @default.
• W2957677739 hasConcept C19527891 @default.
• W2957677739 hasConcept C197947376 @default.
• W2957677739 hasConcept C2989005 @default.
• W2957677739 hasConcept C33923547 @default.
• W2957677739 hasConcept C41008148 @default.
• W2957677739 hasConcept C43214815 @default.
• W2957677739 hasConcept C58693492 @default.
• W2957677739 hasConcept C61863361 @default.
• W2957677739 hasConcept C62520636 @default.
• W2957677739 hasConcept C71924100 @default.
• W2957677739 hasConcept C83849319 @default.
• W2957677739 hasConceptScore W2957677739C114614502 @default.
• W2957677739 hasConceptScore W2957677739C121332964 @default.
• W2957677739 hasConceptScore W2957677739C138496976 @default.
• W2957677739 hasConceptScore W2957677739C154945302 @default.
• W2957677739 hasConceptScore W2957677739C15744967 @default.
• W2957677739 hasConceptScore W2957677739C163258240 @default.
• W2957677739 hasConceptScore W2957677739C169760540 @default.
• W2957677739 hasConceptScore W2957677739C19527891 @default.
• W2957677739 hasConceptScore W2957677739C197947376 @default.
• W2957677739 hasConceptScore W2957677739C2989005 @default.
• W2957677739 hasConceptScore W2957677739C33923547 @default.
• W2957677739 hasConceptScore W2957677739C41008148 @default.
• W2957677739 hasConceptScore W2957677739C43214815 @default.
• W2957677739 hasConceptScore W2957677739C58693492 @default.
• W2957677739 hasConceptScore W2957677739C61863361 @default.
• W2957677739 hasConceptScore W2957677739C62520636 @default.
• W2957677739 hasConceptScore W2957677739C71924100 @default.
• W2957677739 hasConceptScore W2957677739C83849319 @default.
• W2957677739 hasOpenAccess W2957677739 @default.
• W2957677739 hasRelatedWork W1516508131 @default.
• W2957677739 hasRelatedWork W1966976587 @default.
• W2957677739 hasRelatedWork W2084226767 @default.
• W2957677739 hasRelatedWork W2086218312 @default.
• W2957677739 hasRelatedWork W2099724052 @default.
• W2957677739 hasRelatedWork W2330714300 @default.
• W2957677739 hasRelatedWork W2580371235 @default.
• W2957677739 hasRelatedWork W2895673581 @default.
• W2957677739 hasRelatedWork W2913497051 @default.
• W2957677739 hasRelatedWork W2925618103 @default.
• W2957677739 hasRelatedWork W1556065506 @default.
• W2957677739 hasRelatedWork W2412879884 @default.
• W2957677739 hasVolume "59" @default.
• W2957677739 isParatext "false" @default.
• W2957677739 isRetracted "false" @default.

• next